Secretagogin is a hexa EF-hand protein, which has been identified as a novel potential tumour marker. In the present study, we show that secretagogin binds four Ca 2+ ions (log K 1 = 7.1 + − 0.4, log K 2 = 4.7 + − 0.6, log K 3 = 3.6 + − 0.7 and log K 4 = 4.6 + − 0.6 in physiological salt buffers) with a 
INTRODUCTION
Secretagogin is a recently described protein that is expressed in pancreatic islets [1] and the central nervous system, particularly neuroendocrine cells [2, 3] . The secretagogin mRNA was identified as one of the most abundant transcripts in pancreatic islets, highlighting the potential importance of secretagogin in this tissue [1] . Secretagogin is down-regulated in pancreatic islets exposed to high concentrations of glucose [4] , in human non-functional pituitary adenomas [5] and in adenocarcinomas [6] . These results suggest that secretagogin may be involved in suppressing cell growth, and it has been proposed as a novel biomarker for diagnosis of different forms of cancer [7] .
Secretagogin belongs to the HEF (hexa EF-hand) protein family, a group of Ca 2+ -binding proteins within the calmodulin superfamily. Well-known members of the HEF group are calbindin D 28k and calretinin. A high-resolution structure was recently presented for calbindin D 28k [8] , showing a single globular domain comprising all six EF-hands in agreement with earlier fragment complementation studies [9, 10] . Secretagogin exists in three different forms, two of which are characterized by a single amino acid exchange [glutamine (Q)/arginine (R)] at residue 22 (secretagogin Q-22 and secretagogin R-22) [11] . The third form, setagin, does not bind Ca 2+ and consists of only 49 amino acids [11] . Many EF-hand proteins belong to one of two classes: (i) signalling proteins or (ii) buffering proteins. EF-hand proteins that function as Ca 2+ -buffers or transporters have high Ca 2+ affinities (K d < 0.1 µM) and undergo only minor conformational changes upon binding of Ca 2+ (for a review, see [12] ). An important biological function of Ca 2+ -buffer proteins is to maintain nontoxic levels of free intracellular Ca 2+ and to restore the low resting level after signalling events. The signalling proteins (also called Ca 2+ sensors) have lower Ca 2+ affinities (K d > 1 µ M) and undergo significant Ca 2+ -induced conformational changes, which result in exposure or modulation of binding surfaces for target proteins. The target proteins are often activated or attenuated upon complex formation. For example, a Ca 2+ sensor protein may activate protein kinases that initiate cytoplasmic and nuclear actions. These processes are tightly controlled by the Ca 2+ concentration in the cell and the Ca 2+ -binding affinity of the EF-hand protein. In the present study, we have studied the Ca 2+ -binding properties of secretagogin, its conformational response upon Ca 2+ binding and the binding of secretagogin to other proteins.
EXPERIMENTAL Proteins
Human recombinant calbindin D 28k was expressed in Escherichia coli and purified to homogeneity as described in [13] . Human recombinant secretagogin and SNAP-25 (25 kDa synaptosomeassociated protein) were expressed as GST (glutathione Stransferase)-fusion proteins in E. coli. The cells were pelleted and resuspended in ice-cold PBS, and then lysed by passage through a French pressure cell. Insoluble material was pelleted, and the supernatants were loaded on to glutathione-Sepharose columns, which were then washed thoroughly with PBS at 4
• C. Thrombin was added to the columns, which were then incubated on a rocking table at room temperature for 12 h for secretagogin or 2 h for SNAP-25. The thrombin activity was stopped with PMSF, and the cleaved proteins were eluted with PBS. The proteins were further purified on a Pharmacia HiLoad ® 26/60 Superdex 75 prep grade gel filtration column. The concentrations of purified SNAP-25 and secretagogin were determined by amino acid analysis after acid hydrolysis. Ca 2+ -free (apo) protein was prepared in a similar manner as described previously for calbindin D 28k [13] . 1 H NMR spectroscopy was used to verify that the apo samples were free from EGTA.
Far-UV CD spectroscopy
Secretagogin (9 µM; 0.3 mg/ml) in 1 mM DTT (dithiothreitol), 0.5 mM EGTA and 2 mM Tris/HCl (pH 7.5) was used to record the far-UV CD spectra in the far-UV range (185-250 nm). Then, 5 mM MgCl 2 (pH 7.5) was added, and the same measurements were performed again. Finally, 1 mM CaCl 2 (pH 7.5) was added, and the same measurements were repeated. CD spectra were obtained using a Jasco J-720 spectropolarimeter at 25
• C (thermostatically maintained).
Near-UV CD spectroscopy and near-UV absorbance spectroscopy
A protein solution (37 µM secretagogin, in 1 mM DTT, 0.5 mM EGTA and 2 mM Tris, pH 7.5) was used to record the CD and UV spectra in the near-UV range (250-300 nm). Then, 5 mM MgCl 2 (pH 7.5) was added, and the same measurements were performed again. Finally, 1 mM CaCl 2 (pH 7.5) was added, and the same measurements were repeated. UV absorbance measurements were done in a GBC Scientific Equipment (Dandenong, Australia) UV-visible 920 spectrophotometer. CD spectra were obtained using a Jasco J-720 spectropolarimeter at 25
• C (thermostatically maintained). Fluorescence cuvettes made of quartz with path lengths of 10 mm were used.
ANS (8-anilinonaphthalene-l-sulfonic acid) and tryptophan fluorescence spectroscopy
Fluorescence spectra were obtained using a PerkinElmer luminescence spectrometer LS 50 B connected to a Julabo F25 water bath. All data were collected at 25.0
• C using a quartz cuvette (10 mm path length). For tryptophan fluorescence spectra, the excitation wavelength was 295 nm and the emission was scanned between 300 and 450 nm. The excitation slit was 3 nm and the emission slit 3 nm. The ANS fluorescence spectra were recorded between 400 and 600 nm with excitation at 385 nm. The excitation slit was 3 nm and the emission slit 8 nm. A protein solution (5 µM secretagogin in 1 mM DTT, 0.5 mM EGTA, 2 mM Tris/ HCl and 0.15 mM KCl, pH 7.5) was used to record the intrinsic (tryptophan) fluorescence emission spectrum or the ANS fluorescence spectra, in which case the protein was saturated with 120 µM ANS. Then, 5 mM MgCl 2 (pH 7.5) was added and the measurements were performed again. Finally, 1 mM CaCl 2 (pH 7.5) was added and the measurements were repeated.
Macroscopic Ca 2+ -binding constants by the chelator method
The protein (30 µM) was titrated with Ca 2+ in the presence of a chromophoric chelator (25 µM) in 2 mM Tris/HCl (pH 7.5) and 0.15 M KCl. Experiments were performed using the chelators 5,5 -Br 2 -BAPTA [5,5 -dibromobis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid] and 5N-BAPTA (5-nitro-BAPTA). The chelator concentration was determined by absorbance, the Ca 2+ concentrations by atomic-absorbtion spectroscopy and the protein concentration by amino acid analysis after acid hydrolysis. The chelator-protein solutions (1.25 ml) were titrated with 4 µl aliquots of a 2.94 mM CaCl 2 solution, and a few 4 µl aliquots of a 10.7 mM CaCl 2 solution were added at the end of the titration. The titration was monitored as a change in absorbance at 263 nm (5,5 -Br 2 -BAPTA) or 430 nm (5N-BAPTA). Two to three sets of data were obtained for each chelator-protein combination. Parallel experiments were performed in a buffer without salt (2 mM Tris/HCl, pH 7.5). The data were analysed using the Caligator software [14] using a model with a chelator of known Ca 2+ affinity and up to four macroscopic Ca 2+ binding constants for the protein.
ITC (isothermal titration calorimetry)
ITC was carried out using a VP-ITC instrument from Microcal at constant temperature (25 • C) in 2 mM Hepes/NaOH buffer (pH 7.5) with 0 or 150 mM NaCl. Deionized water was used in the reference cell. All solutions were thoroughly degassed by stirring under vacuum before use. CaCl 2 (1 mM) was titrated into 25 µM secretagogin in the sample cell (1.4 ml). For each titration, a 2 µl injection was followed by 40 injections of 4 µl each into the sample cell. The mixture was allowed to react for 4 min between injections. Heats due to injection and dilution were obtained by titrating CaCl 2 into buffer. The data were fitted using the modified Origin software supplied by Microcal. H 0 (enthalpy change) and log K values were obtained by fitting a macroscopic binding model and fits allowing for two, three or four binding sites were attempted.
Limited proteolysis of secretagogin
Secretagogin was dissolved in 50 mM Tris/HCl and 150 mM KCl, containing either 1 mM CaCl 2 or 1 mM EDTA at a protein concentration of 1 mg/ml. The pH was adjusted to 7.5. Sequencing grade modified trypsin (Promega) was dissolved in 50 mM ammonium bicarbonate, yielding a stock solution with a concentration of 0.5 mg/ml. Proteolysis was initiated by mixing 700 µl of secretagogin (1 mg/ml) with 7 µl of the trypsin stock at room temperature. Aliquots of 50 µl were withdrawn at various time points and the digestion was blocked by the addition of 2 µl of soyabean trypsin inhibitor (1 mg/ml) (Boehringer Mannheim; Roche). Peptide fragments from the digestions were analysed by MALDI-TOF (matrix-assisted laser-desorption ionization-time-of-flight). Spectra were acquired on a MALDI-Micro MX (Waters) in linear mode. Sinapinic acid was used as the matrix and an external calibration standard was used for calibration of the spectra. The experimentally measured peptide masses were compared with the theoretical peptides calculated from the human secretagogin sequence by the FindPept tool (http://us.expasy.org/tools/findpept.html). The digested fragments were also separated by SDS/ PAGE (16.5 % gel) in 100 mM Tris/Tricine buffer, pH 8.3. Some Coomassie Blue-stained protein fragments were excised from the gel and identified by LC (liquid chromatography)-MS/MS (tandem MS) as described previously [15] .
Affinity chromatography, SDS/PAGE and identification of proteins
Human recombinant secretagogin or calbindin D 28k were immobilized on CNBr-activated Sepharose. A number of columns were prepared with 3 mg of immobilized protein on 1 ml of CNBractivated Sepharose. Bovine brain tissue (10 g) from two animals or mouse brain tissue (3 g) from ten mice was homogenized using a mixer followed by a Potter-Elvehjem tissue grinder in 20 ml of 50 mM Tris, 150 mM NaCl, 1 mM DTT and 200 µl of protease inhibitor cocktail (Sigma P8340). The homogenate was then centrifuged three times for 6 min at 3000 g and the supernatant was collected and ultracentrifuged at 45 000 rev./min for 90 min using a Beckman 50.2 Ti rotor. The pellet was collected and dissolved by homogenization by a Potter-Elvehjem tissue grinder in 20 ml of a buffer containing detergent [1 % β-dodecyl maltoside, 50 mM Tris, 150 mM NaCl, 1 mM DTT and 200µl of protease inhibitor cocktail (Sigma P8340)]. The pellet fraction was then incubated for 1 h and ultracentrifuged at 100 000 g for 90 min, and the supernatant was collected and divided into two equal parts. CaCl 2 (2 mM) was added to one part and EGTA (2 mM) was added to the other. The samples were ultracentrifuged again at 100 000 g for 90 min and the supernatants were collected and filtered through 45 µM filters. Then, 7 ml of the supernatants was incubated with secretagogin-Sepharose or calbindin D 28k -Sepharose respectively for 2 h. The affinity columns incubated in the presence of 2 mM CaCl 2 were rinsed with 20 column volumes of 50 mM Tris, 0.15 M NaCl, 1 mM DTT and 2 mM CaCl 2 (pH 7.5) containing 0.25 % β-dodecyl maltoside, followed by a two-step elution. First, the columns were eluted with 50 mM Tris, 0.15 NaCl, 1 mM DTT, 2 mM EGTA and 0.25 % β-dodecyl maltoside (pH 7.5), and then by 0.1 M glycine/HCl and 0.25 % β-dodecyl maltoside (pH 2.5). The affinity columns incubated in the presence of 2 mM EGTA were rinsed with 20 column volumes of 50 mM Tris, 0.15 M NaCl, 1 mM DTT and 2 mM EGTA (pH 7.5) containing 0.25 % β-dodecyl maltoside, followed by a two-step elution. First, the columns were eluted with 50 mM Tris, 0.15 NaCl, 1 mM DTT, 2 mM CaCl 2 and 0.25 % β-dodecyl maltoside (pH 7.5) and then by 0.1 M glycine/HCl and 0.25 % β-dodecyl maltoside (pH 2.5). In all cases we checked that no material appeared in the wash (monitored by UV absorption at 280 nm) before elution. The eluates were concentrated by ultra-filtration to 50 µl. Then, 10 µl of the eluates from the secretagogin or calbindin D 28k columns were separated by SDS/PAGE (12 % gel). After the separation of proteins by SDS/PAGE, bands observed only on the secretagogin-gel but not on the calbindin D 28k -gel, were excised from the gel and identified by LC-MS/MS as described previously [15] .
GST pull-down assay
Exponentially growing Rin-5F insulinoma cells were washed in ice-cold PBS and then lysed in cell lysis buffer {TBS [Trisbuffered saline (20 nM Tris/137 nM NaCl)], pH 7.5, containing 1 % Triton X-100, 10 µg/ml aprotinin, 1 µg/ml pepstatin, 10 µg/ml leupeptin, 50 mM PMSF and 0.8 mM Pefabloc}. The cell lysate was precleared by a 5 min spin at 12 000 g. An aliquot (30 µl) of packed fusion protein-loaded glutathioneSepharose 4B beads (GST-secretagogin or GST-setagin) was incubated in 500 µl of Rin-5F cell lysate for 4 h at 4
• C under constant rotation. The beads were then washed four times in cell lysis buffer containing protease inhibitors and finally suspended in SDS sample buffer under reducing conditions. Boiled samples were applied on to an SDS/PAGE (12 % gel) and after electrophoretic protein separation, gels were either stained or blotted on to a nitrocellulose membrane and incubated using a mouse monoclonal SNAP-25 antibody (Sigma; product number: S5187, clone SP12) followed by a goat anti-mouse horseradishperoxidase-conjugated antibody (Dako; product number P 0447).
SPR (surface plasmon resonance) studies
The interaction between calmodulin, calbindin D 28k secretagogin and SNAP-25 was studied using SPR technology on a BIAcore The association and the dissociation of the analyte (SNAP-25) from the chip-immobilized components were studied at several different analyte concentrations. Control experiments were performed using a flow cell, which had been prepared using the immobilization protocol above, but without coupling the protein to the chip dextran surface. The surface was regenerated by injecting 0.1 M HCl for 15 min to remove residual bound analyte.
The association and the dissociation kinetics in the absence or presence of Ca 2+ were studied using buffer A or B as the flow buffers. SNAP-25 was diluted from a concentrated stock into buffer A or B. The surface was regenerated by injecting 0.1 M HCl for 5 min to remove residual bound analyte.
The data were evaluated by a non-linear least-square analysis method using the software KaleidaGraph TM as described previously [9, 10] . solutions.
RESULTS

Since secretagogin has six EF-hand motifs
Far-UV CD spectroscopy
Far-UV CD spectroscopy was used to investigate the secondary structure of secretagogin in the apo, Ca 2+ -and Mg 2+ -bound states. We observed an intense negative ellipticity 208 and 222 nm in the spectra of apo, Ca 2+ -and Mg 2+ -secretagogin (see Supplementary Figure 1 at http://www.BiochemJ.org/bj/401/bj4010353add.htm). This indicates that the protein has significant α-helical character in all forms. Addition of either Ca 2+ or Mg 2+ causes only minor differences in the intensity of each of the 208 and 222 nm bands, suggesting that the binding of each ion induces only minor (A) Near-UV CD spectroscopy. A near UV CD spectrum was first obtained for the apo-protein (37 µM apo-secretagogin in 1 mM DTT, 0.5 mM EGTA and 2 mM Tris/HCl, pH 7.5) (dotted line). MgCl 2 was added to a concentration of 5 mM, and a spectrum for the Mg 2+ form was recorded (broken line). Finally CaCl 2 was added to a concentration of 1 mM, and a spectrum for the Ca 2+ form was recorded (continuous line). (B) Near-UV absorbance spectroscopy. The UV spectrum at room temperature was recorded for a solution of 37 µM secretagogin in 1 mM DTT, 0.5 mM EGTA and 2 mM Tris/HCl (pH 7.5) (apo-secretagogin; dotted line). Then, 5 mM MgCl 2 was added to the same solution (broken line). Finally, 1 mM CaCl 2 was added to the same solution (continuous line).
changes in the secondary structure of the protein. We conclude that the secondary structure is not significantly altered by the binding of Ca 2+ to secretagogin. Similar results have been obtained for the prototypical Ca 2+ sensor calmodulin that displays a modest increase in CD signal on Ca 2+ binding although the highresolution structures of the Ca 2+ and apo states reveal the same number of residues in helical conformation [16] [17] [18] .
Near-UV CD spectroscopy
Secretagogin contains 19 phenylalanine, three tryptophan and five tyrosine residues. The tryptophan and tyrosine signals from approx. 270-295 nm and the strong phenylalanine signals below 270 nm indicate that secretagogin has a significant amount of tertiary structure in the absence of any bound metal ions ( Figure 1A) . No significant change in the near-UV CD spectrum is seen upon addition of 5 mM MgCl 2 . However, the shape of the near-UV CD spectrum of secretagogin, especially between 270 and 290 nm, is markedly altered by addition of 1 mM Ca 2+ . As near-UV CD spectroscopy is sensitive to structural changes in the vicinity of aromatic amino acid side chains or to changes in mobility of aromatic side chains, these results suggest that the tertiary structure of secretagogin is rearranged upon Ca 2+ binding.
UV absorbance spectroscopy
The UV absorbance spectra generated in 0.5 mM EGTA and 5 mM MgCl 2 are highly similar, whereas the shape of the spectrum changes upon addition of 1 mM CaCl 2 ( Figure 1B) . The UV absorbance spectra of secretagogin in the apo and Mg 2+ form display maxima at 282 nm, which is shifted to 280.5 nm when Ca 2+ is added. The UV difference spectrum (results not shown) induced by Ca 2+ binding shows a positive absorbance at 240-283 nm and a negative absorbance between 283 and 310 nm, indicating that a conformational change has occurred in the local environment around aromatic residues upon Ca 2+ binding. A peak seen around 243 nm may reflect increased light scattering in the Ca 2+ state or effects on phenylalanine residues.
Intrinsic fluorescence spectra
Secretagogin contains three tryptophan residues. Two of these are located in the first helix of EF-hand 1 and one is located in the N-terminal helix of EF-hand 3. The tryptophan fluorescence spectrum of the apo form has an emission maximum at 339.5 nm. Addition of 5 mM MgCl 2 does not change the spectrum by any significant degree. Addition of 1 mM CaCl 2 , however, results in a change in the spectrum (Figure 2A ). The Ca 2+ -loaded form displays a higher fluorescence intensity than the apo and Mg 2+ forms (by a factor of ∼ 1.35) and a blue-shift in the maximum emission from 339.5 to 334.5 nm (Figure 2A ). Addition of excess EGTA returns the emission intensity to the initial value (results not shown). The blue-shift in tryptophan fluorescence shows that one or more tryptophan residues become more buried when Ca 2+ is bound. The changes in tryptophan fluorescence may reflect global structural changes. However, they could also be a consequence of more localized rearrangements around the Ca 2+ sites.
Interaction of secretagogin with ANS
The degree of exposed hydrophobic surface in the Ca 2+ and apo states of human recombinant secretagogin was measured using the hydrophobic probe ANS. In the presence of secretagogin, the fluorescence intensity of ANS increases significantly accompanied by a strong blue-shift both in Ca 2+ (60 nm) and EGTA (58 nm) buffers ( Figure 2B ). This suggests that secretagogin has exposed hydrophobic surfaces both in the presence and absence of Ca 2+ . The fluorescence intensity is 2.3 times higher in the Ca 2+ state than in the apo state, and there is a further blue-shift of 2 nm after Ca 2+ addition. The fact that a wavelength shift accompanies the intensity change indicates a true difference in the conformational response between the two forms (i.e. fluorescence quenching cannot explain the observed difference). By monitoring the ANS fluorescence before and after the addition of Ca 2+ , followed by addition of excess of EGTA, we can conclude that the Ca 2+ -induced ANS-fluorescence intensity change is reversible. Mg 2+ addition to secretagogin does not induce any changes in the ANS fluorescence spectrum compared with the apo form, suggesting that the presence of this ion does not change the amount of exposed hydrophobic surface in secretagogin ( Figure 2B ).
Limited proteolysis of secretagogin
Limited tryptic digestion of human recombinant secretagogin was performed in the presence of EGTA and Ca 2+ . The reaction was quenched at different time points ranging from 2 min to Figure 2) . This protein band was identified by MALDI-TOF and sub-digestion followed by peptide identification by LC-MS/MS as consisting of two fragments: residues 48-246 and 12-204. These results suggest that major Ca 2+ -independent cleavage sites are at amino acids 12, 48, 205 and 247. Supplementary Figure 3 (http://www.BiochemJ.org/bj/401/bj4010353add.htm)shows the mass spectra of the digests at 5 and 30 min respectively, and the first and last amino acids are given for all peptides that can be assigned to a specific mass within the secretagogin sequence. Both the rate and pattern of tryptic digestion are Ca 2+ -dependent, although some of the identified peptides are similar in both forms. As shown in Figure 3 ITC was used to analyse the energetics of Ca 2+ binding to secretagogin. For these experiments (and for the titration with Ca 2+ in the presence of chromophoric chelators; see below) we used two different batches of recombinant secretagogin to ensure that our results were reproducible. The purity of both batches was checked by agarose gel electrophoresis in the presence of 1 mM EDTA or 2 mM calcium lactate, SDS/PAGE, isoelectric focusing and MS. 1 H NMR spectroscopy was used to verify that all samples were free from EGTA after preparation of apo-protein. To quantify the residual Ca 2+ concentration in the apo-protein, we performed competition experiments with the high-affinity chelator quin-2. The results suggest that both our batches of recombinant secretagogin are homogenous, intact, free from EGTA and contain 0.3 equiv. of Ca 2+ (results not shown). Titration of CaCl 2 into aposecretagogin in physiological salt concentrations (0.15 M KCl) results in a biphasic curve indicating the presence of two classes of binding sites ( Figures 4C and 4D ). Data were fitted by the Origin software according to a model allowing for co-operative binding. To determine the stoichiometry of binding, we varied the number of binding sites from 1 to 6. The data could not be fitted with one or two binding sites, but was well fitted with three or more binding sites. Binding of Ca 2+ to the first binding site proceeds with a negative enthalpy change, indicating an exothermic process with a H of − 17 kJ/mol, while Ca 2+ binding to the second class of sites is an endothermic process with an average H of + 7 kJ/mol. As the data were fitted equally well with three or four Ca 2+ -binding sites in physiological salt concentrations, we also performed the experiments in low salt ( Figures 4A and 4B ). Again we observed two classes of binding sites. However, the initial exothermic process is significantly less pronounced at low salt. In low salt solutions, Ca 2+ binding to the first site is exothermic with H of − 3 kJ/mol, followed by an endothermic process. At low salt concentrations, the data cannot be fitted with less than one high-affinity site and three low-affinity sites, suggesting that the protein binds four Ca 2+ ions. The Ca 2+ binding affinity (K a ) of the first site is too high to be accurately determined by the present experiments, but could be estimated to approx. 5 × 10 6 M −1 or higher. In low salt solutions, the macroscopic Ca 2+ -binding constants for the three low-affinity sites (K 2 , K 3 and K 4 ) are obtained as log K 2 = 4.3 + − 1.0, log K 3 = 5.5 + − 1.0 and log K 4 = 7.0 + − 1.0 respectively. The average H for these three sites is + 20 kJ/mol, and the data are best fitted when log K 4 > log K 3 > log K 2 , suggesting a high degree of co-operativity of Ca 2+ binding to the low-affinity sites.
Ca
2+ binding determined from competition with chromophoric chelators
To further characterize the Ca 2+ -binding properties of secretagogin, we used titration with Ca 2+ in the presence of chromophoric chelators to determine the macroscopic Ca 2+ -binding constants of secretagogin as described in [19, 20] . In a previous study we used the chelators quin-2 or 5,5 -Br 2 [13] . Since the ITC experiments indicated that secretagogin may contain a set of sites with lower affinity, we used both 5,5 -Br 2 -BAPTA and the chelator 5N-BAPTA, which has lower Ca 2+ affinity [K d (Ca 2+ ) = 27 µM in 0.15 M KCl] than that of quin-2 or 5 -Br 2 -BAPTA. Titrations were also performed in the same buffer with no added salt ( Figure 5 and Table 1 ). The data were analysed by fitting each titration by a model that allows for up to four macroscopic binding constants in the protein using the Caligator software [14] . In accordance with the ITC results, the data suggest that secretagogin binds Ca 2+ to one site with comparatively high affinity (log K 1 = 7.1 + − 0.4 in 0.15 M KCl), which is manifested as a rather flat part in the beginning of the titrations in the presence of 5N-BAPTA ( Figure 5 ), and as a slight curvature in the presence of 5,5 -Br 2 -BAPTA (results not shown). The titrations in the presence of 5N-BAPTA suggest that there are also at least two sites with lower affinity in 0.15 M KCl. Incorporation of a fourth site leads to lower χ 2 (for a definition of χ 2 , see [14] ), but the change is not significant given that more parameters are introduced. Thus the data from the chelator experiments are equally well fitted with three or four binding-sites. If we assume that secretagogin binds four Ca 2+ ions, as suggested by the ITC experiments, the following affinities are obtained in physiological salt buffers: log K 1 = 7.1 + − 0.4, log K 2 = 4.7 + − 0.6, log K 3 = 3.6 + − 0.7 and log K 4 = 4.6 + − 0.6. All data sets are best fitted if K 4 is at least an order of magnitude larger than K 3 , implying strong positive cooperativity of Ca 2+ binding to the low-affinity sites [21] . This is seen as a sigmoidal shape in the titration data after the saturation of the high-affinity site. The Ca 2+ concentration required to achieve half-maximal saturation of secretagogin in 0.15 M KCl is approx. 25 µM. At low salt concentrations secretagogin binds Ca 2+ to four sites with the following affinities: log K 1 = 8.0 + − 0.3, log K 2 = 5.0 + − 0.1, log K 3 = 3.0 + − 0.1 and log K 4 = 5.5 + − 0.3. Again, the data are better fitted if K 4 is at least an order of magnitude larger than K 3 , implying positive co-operativity among the low-affinity sites. We used two batches of recombinant secretagogin, both of which gave similar results. Altogether nine titrations (four and five titrations each of the two batches of recombinant secretagogin) were performed using 5N-BAPTA. In order to confirm that the binding constants obtained by the chelator method are in the correct range, we monitored Ca 2+ binding by tryptophan and ANS fluorescence. Although the titration monitored by tryptophan and ANS fluorescence does not provide the high precision obtained using the competitive chromophoric chelator method, it does confirm that the binding constants obtained by the chelator method are in the correct range (see supplementary material at http://www.BiochemJ.org/bj/401/ bj4010353add.htm).
Identification of secretagogin-binding proteins
Ca
2+ sensor proteins such as calmodulin often interact with target proteins. We investigated if secretagogin binds to specific targets by affinity chromatography using immobilized recombinant secretagogin. In order to identify bona fide interacting proteins versus sample contaminants, we conducted negative controls in parallel using Sepharose 4B cross-linked to human recombinant calbindin D 28k . Calbindin D 28k was selected as control protein because it is very similar to secretagogin based on homology searches performed using the BLAST 2 software (58 % sequence similarity). Like secretagogin, calbindin D 28k is an HEF protein belonging to the calmodulin protein superfamily [3, 22] . We performed the experiments using brain homogenates from two different species (mouse and cow) and by using pull-downs from the rat insulinoma cell line RIN-5F. All eluates were concentrated and separated by SDS/PAGE. Protein bands that appeared to bind specifically to the secretagogin column were excised and digested with trypsin and the resulting peptides were identified by ('Calb')-Sepharose respectively for 2 h. The affinity columns were then rinsed followed by elution with a buffer containing 2 mM EGTA. The eluates from all experiments were concentrated by ultra-filtration to 50 µl, and 10 µl was separated by SDS/PAGE. Bands indicated with arrows were cut and processed for MS/MS (gel slice named 'Sec'). (C) GST-secretagogin or GST-setagin was incubated with cell extracts from RIN-5F cells and pulled down using glutathione beads. After washing the beads, they were boiled in SDS/PAGE sample buffer, centrifuged and transferred on to PVDF membranes and stained or probed using anti-SNAP-25 antibodies.
LC-MS/MS. Experiments were performed using both cytosolic fractions (tissue homogenized without detergent) and membrane fractions (tissue homogenized in the presence of detergent in order to solubilize membrane-associated proteins). Although a small number of proteins (e.g. protein kinase C, N-ethylmaleimide-sensitive fusion protein and caskin-1) were identified from secretagogin affinity chromatography experiments using cytosolic fractions, these proteins did not pass the criteria we set up for accepting a protein as a specific secretagogin-binding protein.
Thus they were either not reproducibly identified or they were also found in the eluates from the calbindin D 28k control columns (results not shown). When using membrane fractions for the affinity chromatography experiments, however, SNAP-25 was identified as a specifically binding protein in all experiments. Below we therefore describe only the affinity chromatography experiments performed using membrane fractions.
The first experiment was designed to purify proteins binding to Ca 2+ -secretagogin in mouse brain membrane fractions (Figure 6A ). CaCl 2 (2 mM) was included when solubilizing the brain extract, which was then incubated with secretagogin-Sepharose or calbindin D 28k -Sepharose. Each column was eluted with 5 ml of a buffer containing 2 mM EGTA. A protein band that was found in the eluate from the secretagogin column, but not in the eluate from the calbindin D 28k column, was identified by LC-MS/MS as SNAP-25 with a Mascot score of 50 (corresponding to a P value of < 0.0005, i.e. the statistical probability of a correct protein identification is 99.95 %) and five identified peptides (MLQLVEESK, EQMAISGGFIR, ADQLADESLESTRR, MLQLVEESKDAGIR and TLVMLDEQGEQLER).
The second experiment was designed to purify proteins binding to Ca 2+ -secretagogin from bovine brain membrane fractions. The secretagogin and calbindin D 28k columns were incubated with bovine brain homogenates in the presence of 2 mM CaCl 2 and washed and proteins were eluted with 5 ml of a buffer containing EGTA. The identity of a 30 kDa band present in the eluate from the secretagogin column was determined to be SNAP-25 by LC-MS/MS ( Figure 6B ). This band was not seen in the eluate from the calbindin D 28k column ( Figure 6B ). Three different peptides (CCGLFICPCNKLK and TLVMLDEQLDR from SNAP-25a and TLVMLDEQLER from SNAP-25b) were identified with a Mascot score of 68 (corresponding to a P value of < 0.00005, i.e. the statistical probability of a correct protein identification is 99.995 %).
The third experiment was designed to identify proteins binding to apo-secretagogin from mouse brain membrane fractions. Two columns with immobilized secretagogin and two columns with immobilized calbindin D 28k were prepared and incubated separately with homogenized mouse brain tissue in the presence of 2 mM EGTA. Proteins binding to these columns were first eluted by a buffer containing 2 mM CaCl 2 . No protein bands could bee seen in the eluates from the secretagogin columns (results not shown). The columns were then eluted with glycine/HCl (pH 2.5). LC-MS/MS identified SNAP-25 in the eluates from the two secretagogin columns, but not in the eluates from the two calbindin D 28k columns (results not shown). SNAP-25 was identified from the first secretagogin column with a Mascot score of 82 (corresponding to a P value of < 10 −6 ) and with seven identified tryptic peptides (MLQLVEESK, IEEGMDQINK, EQMAISGGFIR, ADQLADESLESTR, MLQLVEESKDAGIR, TLVMLDEQGE-QLER and HMALDMGNEIDTQNR) and from the second secretagogin column with a Mascot score of 193 (corresponding to a P value of < 10 −6 ) and with seven identified tryptic peptides (MLQLVEESK, IEEGMDQINK, EQMAISGGFIR, ADQLA-DESLESTR, IEEGMDQINKDMK, RADQLADESLESTR and MLQLVEESKDAGIR). These results suggest that secretagogin binds to SNAP-25 also in the absence of Ca 2+ . Secretagogin is not only expressed in the brain, but also abundantly expressed in neuroendocrine cells in the pancreas. The fourth experiment was designed to investigate the binding between secretagogin and SNAP-25 in a pancreatic cell line. For this purpose, immobilized GST-secretagogin fusion protein was used to affinity-purify ('pull-down') proteins from a membrane preparation of the β-cell line RIN-5F. GST-secretagogin protein was able to pull down endogenous SNAP-25 from RIN-5F cells. In contrast, control GST or GST-setagin was unable to pull down SNAP-25 ( Figure 6C ). Setagin is a 5.6 kDa splice variant of secretagogin that contains only a segment of the first EF-hand [11] .
SPR was used to study the binding kinetics and affinity between secretagogin and SNAP-25 in vitro. SNAP-25 was overexpressed in E. coli and purified as described in the Experimental section. The amount of immobilized secretagogin was approx. 2500 resonance units in pg/mm 2 . The interaction between the two proteins was studied at four different SNAP-25 concentrations ranging from 25 nM to 4.5 µM. The curves representing the three lowest SNAP-25 concentrations (25, 180 and 900 nM) were used for fitting. The sensorgrams indicate that the two proteins interact with high affinity in the presence of Ca 2+ . Based on the values of k on and k off (see Table 2 ), the equilibrium dissociation constant K d in the presence of Ca 2+ was determined to be 1.2 × 10 −7 M. The affinity is reduced by a factor of 8 in the absence of Ca
The difference between the Ca 2+ and EDTA forms seems to be in k off , indicating that secretagogin dissociates from SNAP-25 more rapidly in the absence of Ca 2+ (see Table 2 ). We also performed SPR control experiments with immobilized calbindin D 28k and calmodulin under identical conditions as above. Secretagogin binds strongly to SNAP-25 in Ca 2+ buffers and somewhat weaker in EDTA buffers (Figure 7 ). Calbindin D 28k and calmodulin, on the other hand, do not bind to SNAP-25 in the presence of Ca 2+ (Figure 7 ) or in the presence of EDTA (results not shown). [13, 23, 24] . The ANS-fluorescence studies also indicate that the Ca 2+ -loaded form of secretagogin is more hydrophobic than the Ca 2+ -free form. The exposure of hydrophobic surfaces is thermodynamically unfavourable. An obvious way of minimizing the exposed hydrophobic surfaces is by the interaction with other proteins. Thus it is possible that the hydrophobic patch at the surface of secretagogin may be instrumental for interaction with (and functional regulation of) other proteins.
DISCUSSION
Our results suggest that secretagogin binds four Ca 2+ ions. We find it likely that EF-hands 3, 4, 5 and 6 are responsible for the binding of Ca 2+ ions to secretagogin. This is because the amino acid sequences of EF-hands 1 and 2 do not conform to the EFhand consensus sequence. EF-hand 1 has a lysine residue at a position where normally an aspartic acid or asparagine side chain provides an oxygen to co-ordinate Ca 2+ . The loop of EF-hand 2 has the standard Ca 2+ -co-ordinating groups, but in one position there is a positively charged arginine where a normally negative or hydrophilic side chain hydrogen-bonds to a Ca 2+ -co-ordinating water molecule in the same loop. Therefore these two EF-hands are most likely the ones that are non-functional in terms of Ca 2+ ions with high affinity and positive co-operativity [13, 25] . ITC experiments performed with calbindin D 28k show a single exothermic process that requires 4 equiv. of Ca 2+ to reach saturation and the affinity is too high to be quantified (S. Linse, unpublished work). However, for secretagogin ITC data are clearly biphasic, and the sites act in two groups; one with high-moderate affinity and negative reaction enthalpy, and one group with lower affinity, positive enthalpy and co-operativity. [26] [27] [28] , which is in the same range as measured here for secretagogin. This information is particularly interesting since synaptotagmin I binds to SNAP-25, the same protein that was identified in this study as a potential secretagogin-binding protein. Alternatively, the requirement for higher Ca 2+ concentrations may be similar to the situation with the cytoplasmic calpains (for a review, see [29] saturation curves, allowing only a small fraction of the calpain pool to become activated [29] .
We recently completed a study in which we identified a large number of proteins in EGTA eluates from calmodulin affinity columns [15] . When comparing those results with those from the present study, it is clear that secretagogin does not bind a very large number of proteins as observed for calmodulin. Although we cannot exclude the existence of other secretagogininteracting proteins, SNAP-25 was the only protein that we could identify from all tissues and species used. Unlike secretagogin, the related proteins calbindin D 28k and the promiscuous Ca 2+ sensor calmodulin were unable to bind SNAP-25. These results indicate that the interaction between secretagogin and SNAP-25 is highly specific. SNAP-25 is one of the basic components of the SNARE (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor) complex. The SNARE complex is the core complex for membrane fusion, a process that is regulated by changes in intracellular Ca 2+ levels (for reviews, see [34] [35] [36] ). Secretagogin is expressed in neuroendocrine cells in the brain and in the pancreatic islets [1] [2] [3] , which are sites of exocytosis of neurotransmitters and insulin respectively. Thus secretagogin and SNAP-25 seem to be expressed in the same type of cells.
SNAP-25 could be eluted from secretagogin columns by buffers containing Ca 2+ chelators, suggesting that the interaction is at least partially Ca 2+ -dependent. The apparent affinity of the interaction increases approx. 10 [40] with the apparent affinity of the interaction increasing only approx. 6-fold following addition of Ca 2+ [41] . Thus the triggering of fast exocytosis by Ca 2+ binding to synaptotagmin I is not executed via Ca 2+ -induced binding of synaptotagmin I to SNAP-25 and other SNAREs [42] . Ca 2+ -independent binding of synaptotagmin I to SNAREs serves to position synaptotagmin I next to SNARE complexes after these have been assembled but before the fusion pore has opened [34] . Ca 2+ then induces a conformational change in the prebound synaptotagmin that results in a series of events that opens the fusion pore. Similarly, formation of a complex between secretagogin and SNAP-25 at resting Ca 2+ concentrations could, in theory, allow Ca 2+ -induced structural changes of secretagogin to be rapidly transmitted to elicit a functional change. An investigation of the possible role of secretagogin in exocytosis is an important question for the future. [43] . The differences in Ca 2+ affinities probably reflect important biological and evolutionary differences between these proteins. The comparatively low Ca 2+ affinity of secretagogin makes it unlikely to function as an efficient Ca 2+ -buffer protein, although the high-affinity site may provide some buffering capacity. The amount of exposed hydrophobic surface in secretagogin increases upon Ca 2+ binding and it undergoes Ca 2+ -induced conformational changes, suggesting the possibility that it can transduce intracellular Ca 2+ -concentration changes to other proteins. Secretagogin does not interact with a large number of proteins as observed for e.g. calmodulin. Only SNAP-25, a protein involved in Ca 2+ regulated exocytosis, could be reproducibly identified as a secretagogin-binding protein.
Conclusions
